Patients who Participated in Pleio GoodStart™ Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient

Share Article

Patients who participated in Pleio GoodStart™ refilled 30% sooner and 40% more, averaging 2 additional Rx refills per patient during first 9 months of therapy.

Source: Pleio retail pharmacy prescription data from US Mid-Atlantic Pharmacy Chain, May 2008 -- October 2009

Pleio Health Support Systems, Inc. (Pleio) announces updated results of the Pleio GoodStart™ medication adherence program. Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart™ had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).

Data also showed that patients who participated in the GoodStart™ program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart™ program.

"Improving people's experience with new prescription medications involves many disciplines. Pleio's technology, pharmacy and manufacturer partners are equally dedicated to improving the patient experience with new prescriptions. These results show that when elderly patients are carefully listened to, stimulated in language they can relate to, and empowered with performance support, adherence challenges are easily overcome." For more information about Pleio GoodStart, contact Pleio at (514) 369-9995 or info(at)pleio.com.

Pleio GoodStart™ Connects Pharmacies, Patients, Coaches and Personal Media for Patients' First 100 Days of Medication Therapy

Pleio GoodStart connects physicians, patients, pharmacies, families and pharmaceutical manufacturers toward their common goal of improved patient adherence. Physicians gain the assurance that their patients will be well-supported and that future patient appointments can be more effective. Pharmacies are provided a new perspective on C&P through training and feedback on patient progress. Patients receive unprecedented interest in their welfare throughout the medication adoption phase, with up to 75 contacts during their first 100 days on therapy. Family and friend support is stimulated through awareness of the issue of adherence and their potential to be an advocate.

About Pleio Health Support Systems, Inc.

Pleio Health Supports Systems, founded in 2006, has offices in Montreal and Boston. Pleio GoodStart™ is a sponsored adherence program that helps patients properly adopt new medications and in turn refill more prescriptions over a longer period of time. Pleio GoodStart™ is a registered trademark of Pleio Health Support Systems, Inc. For more information, visit http://www.pleio.com or contact Jean Lalonde, at (514) 369-9995 info(at)pleio.com.

About Medication Adherence

Since a full 75 percent of U.S. health care spending goes to the treatment of chronic disease, poor medication adherence presents a serious roadblock to efforts to improve health care efficiency and affordability. Nonadherence has been shown to result in $100 billion each year in excess hospitalizations alone. Patient non-adherence is quickly becoming a significant issue within the healthcare industry. Poor adherence often leads to preventable worsening of disease, posing serious and unnecessary health risks, particularly for patients with chronic illnesses. An estimated one third to one half of all patients in the U.S. do not take their medications as prescribed by their doctors.(1) The New England Health (NEHI) estimates that non-adherence along with suboptimal prescribing, drug administration, and diagnosis could result in as much as $290 billion per year in avoidable medical spending or 13 percent of total health care expenditures.

(1) Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. New England Health Initiative

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jean Lalonde
Visit website